Inventor · Upper Arlington, OH, US

Christopher C. Coss

14Patents
7h-index
15Co-inventors
55Inventor score

Filing activity: Oct 24, 2014 → Dec 19, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9815776B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Chemistry; Metallurgy 11 Active
US9834507B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Chemistry; Metallurgy 11 Active
US10035763B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Chemistry; Metallurgy 10 Active
US9814698B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Chemistry; Metallurgy 10 Active
US10017471B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Chemistry; Metallurgy 10 Active
US10441570B2 Selective androgen receptor degrader (SARD) Ligands and methods of use thereof Human Necessities 9 Active
US10093613B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Human Necessities 8 Active
US10597354B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Human Necessities 7 Active
US11273147B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Human Necessities 5 Active
US9624161B2 Estrogen receptor ligands and methods of use thereof Chemistry; Metallurgy 4 Active
US11591290B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Human Necessities 2 Active
US11529323B2 Methods and compositions for the treatment of cancer cachexia Human Necessities 0 Active
US12128026B2 Selective androgen receptor degrader (SARD) ligands and methods of use thereof Human Necessities 0 Active
US11938105B1 Methods and compositions for the treatment of cancer cachexia Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.